Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart J Pocock

Showing results (251-260 of 349) with videos related to

Pageof 35
Sort By:
European Journal of Heart Failure|April 1, 2024
Body mass index and cardiorenal outcomes in the EMPEROR-Preserved trial: Principal findings and meta-analysis with the DELIVER trialNaveed Sattar, Javed Butler, Matthew M Y Lee, et al.
Circulation|August 30, 2021
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved TrialMilton Packer, Javed Butler, Faiez Zannad, et al.
JACC. Heart Failure|February 3, 2025
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Preserved TrialPeter Carson, John R Teerlink, Michel Komajda, et al.
Clinical Cardiology|July 4, 2020
Long-term antithrombotic management patterns in Asian patients with acute coronary syndrome: 2-year observations from the EPICOR Asia studyBo Zheng, Yong Huo, Stephen W-L Lee, et al.
JAMA Cardiology|May 24, 2023
Safety and Efficacy of Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction: A Post Hoc Analysis of the EMPEROR-Preserved TrialJaved Butler, Muhammad Shariq Usman, Gerasimos Filippatos, et al.
International Journal of Cardiology|May 12, 2020
Two-year outcomes post-discharge in Asian patients with acute coronary syndrome: Findings from the EPICOR Asia studyYong Huo, Stephen W-L Lee, Jitendra P S Sawhney, et al.
Journal of the American College of Cardiology|November 10, 2022
Hospitalizations and Mortality in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT TrialGennaro Giustino, Anton Camaj, Samir R Kapadia, et al.
European Heart Journal|April 9, 2009
Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trialRoxana Mehran, Stuart J Pocock, Gregg W Stone, et al.
International Journal of Cardiology|February 15, 2020
Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countriesDavid Brieger, Stuart J Pocock, Stefan Blankenberg, et al.
Revista Espanola De Cardiologia (English Ed.)|October 24, 2021
The Clinical outcomes, healthcare resource utilization, and related costs (COHERENT) model. Application in heart failure patientsHéctor Bueno, José L Bernal, Víctor Jiménez-Jiménez, et al.
Pageof 35

Showing results (251-260 of 349) with videos related to

Sort By:
Pageof 35
European Journal of Heart Failure|April 1, 2024
Body mass index and cardiorenal outcomes in the EMPEROR-Preserved trial: Principal findings and meta-analysis with the DELIVER trialNaveed Sattar, Javed Butler, Matthew M Y Lee, et al.
Circulation|August 30, 2021
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved TrialMilton Packer, Javed Butler, Faiez Zannad, et al.
JACC. Heart Failure|February 3, 2025
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Preserved TrialPeter Carson, John R Teerlink, Michel Komajda, et al.
Clinical Cardiology|July 4, 2020
Long-term antithrombotic management patterns in Asian patients with acute coronary syndrome: 2-year observations from the EPICOR Asia studyBo Zheng, Yong Huo, Stephen W-L Lee, et al.
JAMA Cardiology|May 24, 2023
Safety and Efficacy of Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction: A Post Hoc Analysis of the EMPEROR-Preserved TrialJaved Butler, Muhammad Shariq Usman, Gerasimos Filippatos, et al.
International Journal of Cardiology|May 12, 2020
Two-year outcomes post-discharge in Asian patients with acute coronary syndrome: Findings from the EPICOR Asia studyYong Huo, Stephen W-L Lee, Jitendra P S Sawhney, et al.
Journal of the American College of Cardiology|November 10, 2022
Hospitalizations and Mortality in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT TrialGennaro Giustino, Anton Camaj, Samir R Kapadia, et al.
European Heart Journal|April 9, 2009
Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trialRoxana Mehran, Stuart J Pocock, Gregg W Stone, et al.
International Journal of Cardiology|February 15, 2020
Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countriesDavid Brieger, Stuart J Pocock, Stefan Blankenberg, et al.
Revista Espanola De Cardiologia (English Ed.)|October 24, 2021
The Clinical outcomes, healthcare resource utilization, and related costs (COHERENT) model. Application in heart failure patientsHéctor Bueno, José L Bernal, Víctor Jiménez-Jiménez, et al.
Pageof 35